SEC Form 4 · accession 0001209191-18-062125
Tempest Therapeutics, Inc. · TPST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Pharis Mohideen
Officer — Chief Medical Officer
Period of report
Dec 7, 2018
Accepted (ET)
Dec 11, 2018 · 7:48 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001544227
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 7, 2018 | A | 7,440 | — | A | 7,440 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F3,F2 | $2.69 | Dec 7, 2018 | A | 19,258 | A | — | Dec 4, 2024 | Common Stock | 19,258 | 19,258 | D |
| Employee Stock Option (right to buy)F5,F4 | $4.44 | Dec 7, 2018 | A | 37,485 | A | — | Jan 27, 2026 | Common Stock | 37,485 | 37,485 | D |
| Employee Stock Option (right to buy)F7,F6 | $16.40 | Dec 7, 2018 | A | 40,919 | A | — | Aug 23, 2028 | Common Stock | 40,919 | 40,919 | D |
Explanation of responses
- F1Received in exchange for 100,000 shares of Millendo Therapeutics, Inc. ("Millendo") common stock in connection with merger of Millendo Therapeutics, Inc. into the Issuer (the "Merger").
- F2Fully vested.
- F3Received in connection with the Merger in exchange for a stock option to acquire 258,845 shares of Millendo common stock for $0.20 per share.
- F4Twenty-five percent (25%) of the shares subject to the option vested on January 28, 2017, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
- F5Received in connection with the Merger in exchange for a stock option to acquire 503,847 shares of Millendo common stock for $0.33 per share.
- F6Twenty-five percent (25%) of the shares subject to the option shall vest on August 20, 2019, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
- F7Received in connection with the Merger in exchange for a stock option to acquire 550,000 shares of Millendo common stock for $1.22 per share.